Research / TSLA / Fundamental state Inspectable configuration
State dimensions Filing 0001564590-20-004475 General Corporate
Debt relative to revenue RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.debt_to_revenue
42.32% · OPTIONAL · NOT_ENOUGH_HISTORY
Capex intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.capex_revenue_ratio
5.40% · OPTIONAL · NOT_ENOUGH_HISTORY
Operating cash generation RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
9.79% · OPTIONAL · NOT_ENOUGH_HISTORY
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
14.52% · CORE · NOT_ENOUGH_HISTORY
Inventory pressure RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
14.45% · OPTIONAL · NOT_ENOUGH_HISTORY
Gross margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.gross_margin
16.56% · CORE · NOT_ENOUGH_HISTORY
Operating margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.operating_margin
-0.28% · CORE · NOT_ENOUGH_HISTORY
R&D intensity RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
5.46% · OPTIONAL · NOT_ENOUGH_HISTORY
SBC intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
3.65% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 24 states Self-history eligible
Mar 31, 2019 0/9 normalized Level 3 Jun 30, 2019 0/9 normalized Level 3 Sep 30, 2019 0/9 normalized Level 3 Dec 31, 2019 0/9 normalized Level 3 Mar 31, 2020 7/9 normalized Level 3 Jun 30, 2020 7/9 normalized Level 3 Sep 30, 2020 8/9 normalized Level 3 Dec 31, 2020 8/9 normalized Level 3 Mar 31, 2021 9/9 normalized Level 3 Jun 30, 2021 9/9 normalized Level 3 Sep 30, 2021 9/9 normalized Level 3 Dec 31, 2021 9/9 normalized Level 3 Mar 31, 2022 9/9 normalized Level 3 Jun 30, 2022 9/9 normalized Level 3 Sep 30, 2022 9/9 normalized Level 3 Dec 31, 2022 9/9 normalized Level 3 Mar 31, 2023 9/9 normalized Level 3 Jun 30, 2023 9/9 normalized Level 3 Sep 30, 2023 9/9 normalized Level 3 Sep 30, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 160.18%
Current 42.32%
Delta -117.86% Capex Intensity Decreased
Previous 6.11%
Current 5.40%
Delta -0.72% Cash Generation Decreased
Previous 11.99%
Current 9.79%
Delta -2.21% Growth Increased
Previous -7.64%
Current 14.52%
Delta 22.16% Inventory Pressure Decreased
Previous 56.81%
Current 14.45%
Delta -42.36% Margin Decreased
Previous 18.90%
Current 16.56%
Delta -2.34% Profitability Decreased
Previous 4.14%
Current -0.28%
Delta -4.42% R And D Intensity Increased
Previous 5.30%
Current 5.46%
Delta 0.17% Sbc Intensity Increased
Previous 3.16%
Current 3.65%
Delta 0.50% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.